Pluribus Labs’s Macerich MAC Stock Holding History

Pluribus Labs’s Portfolio MAC Stock Details MAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,949	Closed	-$206K	–	160
2021 Q4	$206K	Buy	+11,949	New	+$224K	0.22%	208

Other funds holding MAC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

ACM

AEW Capital Management Boston, Massachusetts $1.38B AUM 4.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Pluribus Labs's MAC Position: Q1 2022 in Review

Pluribus Labs sold out of Macerich (MAC) in Q1 2022, closing a stake of 11,949 shares — an estimated $206K sold.

Pluribus Labs first reported a position in MAC in Q4 2021 and held it in 1 quarter. The position peaked at $206K in Q4 2021. 307 funds tracked by Wall St. Rank hold MAC as of Q1 2022.

Pluribus Labs reported no remaining Macerich position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 11,949 Macerich shares in Q1 2022, an estimated $206K.
Pluribus Labs first reported a position in Macerich in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Macerich position peaked at $206K in Q4 2021.
307 funds tracked by Wall St. Rank held Macerich as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.